UPDATE 5/10/2021 Fully Operational as COVID-19 Continues

Paul Marron
Paul Marron
May 10, 2021

 As the COVID-19 pandemic endures, Tully Hill remains fully operational to provide 24/7 Inpatient (medically supervised detox, intensive Inpatient rehabilitation) and Outpatient (Outpatient and Intensive Outpatient via Telehealth services) treatment and care, as the COVID-19 pandemic persists and continues to greatly affect the substance use disorder treatment community.

Our Intake staff in admissions, working closely with our medical staff, will continue to collaborate with referrals to facilitate and expedite on-site evaluations and admissions with which there are COVID-19-related issues.

We are pleased to be able to report that throughout the entire COVID-19 pandemic to date, largely because of this ongoing, collective staff teamwork , we have not had any cases of patients either testing positive for COVID-19 or who developed any COVID-19-related illness, while in treatment and care. In addition, we have had no known cases of discharged patients testing positive or becoming sick from the virus, within two weeks after discharge from treatment and care.

Thank you for working with us and understanding the need to keep our patients and employees safe and healthy, during the COVID-19 pandemic.  

Paul Marron

Director of Business Development

Paul Marron, Director of Business Development, joined Tully Hill Chemical Dependency Treatment Center in July 2012. Mr. Marron graduated Magna Cum Laude from both Saint Bonaventure University with a BA, History/Pre-Law and Boston University with his MS, Public Relations. He worked most recently at Central New York Eye & Tissue Bank where he served as their Director of Business Development. He has extensive experience in healthcare administration, contracting, marketing and development in Central New York.